The study by Hendren et al
Dihexa, or N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, first known PNB-0408, is a novel nootropic compound and experimental drug that has been developed for possible treatment of trauma-based brain disorders and neurodegenerative conditions (i.e., Alzheimers, Parkinsons) that would compensate for arisen cognitive deficits through increased synaptogenesis
Copper peptides prolong anagen while shortening telogen
Since T3 directly stimulates hair follicle keratinocyte proliferation, even subtle declines can slow hair growth or push follicles into premature catagen and telogen
They are not for human consumption and are not intended to diagnose, treat, cure, or prevent plantar fasciitis, chronic foot pain, sports injuries, soft tissue injury, inflammation, pain, stiffness, reduced mobility, recovery delay, performance decline, or any medical condition